Document is current
Any future updates will be listed below
-
Authors
Kovalchin, Claire E.
Kaffenberger, Jessica
Trinidad, John
Gilkey, Ty W.
Minta, Abena
Gudjonsson, Johann
Kaffenberger, Benjamin H.
- License Information
-
More Information
Article History
Received: 1 June 2022
Revised: 8 December 2022
Accepted: 10 January 2023
First Online: 20 January 2023
Competing interests
: Dr. Benjamin Kaffenberger is an investigator for AnaptysBio, Biogen, InflaRx, OnQuality Pharmaceuticals and the Dermatology Foundation
